|
1
|
Hedinger C, Williams ED and Sobin LH: The
WHO histological classification of thyroid tumors: a commentary on
the second edition. Cancer. 63:908–911. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cooper DS, Doherty GM, Haugen BR, et al:
Revised American Thyroid Association management guidelines for
patients with thyroid nodules and differentiated thyroid cancer.
Thyroid. 19:1167–1214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pfister DG, Spencer S, Brizel DM, et al:
Head and neck cancers, Version 2.2014. Clinical practice guidelines
in oncology. J Natl Compr Canc Netw. 12:1454–1487. 2014.PubMed/NCBI
|
|
4
|
Pacini F, Castagna MG, Brilli L and
Pentheroudakis G: ESMO Guidelines Working Group: Thyroid cancer:
ESMO Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. Suppl 7:vii110–vii119. 2012.PubMed/NCBI
|
|
5
|
Yoshida A: Guidelines for the management
of thyroid tumors. Nihon Geka Gakkai Zasshi. 113:507–601. 2012.(In
Japanese). PubMed/NCBI
|
|
6
|
Takami H, Ito Y, Okamoto T, Onoda N,
Noguchi H and Yoshida A: Revisiting the guidelines issued by the
Japanese Society of thyroid surgeons and Japan association of
endocrine surgeons: a gradual move towards consensus between
Japanese and western practice in the management of thyroid
carcinoma. World J Surg. 38:2002–2010. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
The Japanese Society of Thyroid Surgery
and The Japanese Association of Endocrine Surgeons, . Guidelines
for Management of Thyroid Tumor. Kanehara Press; Tokyo: 2010
|
|
8
|
Teng W, Liu YF, Gao M and Huang G:
Management guidelines for patients with thyroid nodules and
differentiated thyroid cancer. Chin J Clin Oncol. 17:1249–1272.
2012.(In Chinese).
|
|
9
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khairy GA and Al-Saif A: Incidental
parathyroidectomy during thyroid resection: incidence, risk
factors, and outcome. Ann Saudi Med. 31:274–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burningham AR, Krishnan J, Davidson BJ,
Ringel MD and Burman KD: Papillary and follicular variant of
papillary carcinoma of the thyroid: initial presentation and
response to therapy. Otolaryngol Head Neck Surg. 132:840–844. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xing M, Westra WH, Tufano RP, et al: BRAF
mutation predicts a poorer clinical prognosis for papillary thyroid
cancer. J Clin Endocrinol Metab. 90:6373–6379. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xing M, Liu R, Liu X, et al: BRAF V600E
and TERT promoter mutations cooperatively identify the most
aggressive papillary thyroid cancer with highest recurrence. J Clin
Oncol. 32:2718–2726. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH
and Lim YC: Predictive factors for ipsilateral or contralateral
central lymph node metastasis in unilateral papillary thyroid
carcinoma. Ann Surg. 249:840–844. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Handkiewicz-Junak D, Wloch J, Czarniecka
A, et al: Completion total thyroidectomy in children with
differentiated thyroid cancer. Endokrynol Pol. 57:356–361. 2006.(In
Polish). PubMed/NCBI
|
|
16
|
Chung YS, Kim JY, Bae JS, et al: Lateral
lymph node metastasis in papillary thyroid carcinoma: results of
therapeutic lymph node dissection. Thyroid. 19:241–246. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shindo M, Wu JC, Park EE and Tanzella F:
The importance of central compartment elective lymph node excision
in the staging and treatment of papillary thyroid cancer. Arch
Otolaryngol Head Neck Surg. 132:650–654. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mercante G, Frasoldati A, Pedroni C, et
al: Prognostic factors affecting neck lymph node recurrence and
distant metastasis in papillary microcarcinoma of the thyroid:
results of a study in 445 patients. Thyroid. 19:707–716. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McCarthy RP, Wang M, Jones TD, Strate RW
and Cheng L: Molecular evidence for the same clonal origin of
multifocal papillary thyroid carcinomas. Clin Cancer Res.
12:2414–2418. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chow SM, Law SC, Chan JK, Au SK, Yau S and
Lau WH: Papillary microcarcinoma of the thyroid - prognostic
significance of lymph node metastasis and multifocality. Cancer.
98:31–40. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harach HR, Franssila KO and Wasenius VM:
Occult papillary carcinoma of the thyroid. A ‘normal’ finding in
Finland. A systematic autopsy study. Cancer. 56:531–538. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ito Y, Tomoda C, Uruno T, et al:
Prognostic significance of extrathyroid extension of papillary
thyroid carcinoma: massive but not minimal extension affects the
relapse-free survival. World J Surg. 30:780–786. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ito Y, Miyauchi A, Inoue H, et al: An
observational trial for papillary thyroid microcarcinoma in
Japanese patients. World J Surg. 34:28–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ito Y, Jikuzono T, Higashiyama T, et al:
Clinical significance of lymph node metastasis of thyroid papillary
carcinoma located in one lobe. World J Surg. 30:1821–1828. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Noguchi S, Yamashita H, Murakami N,
Nakayama I, Toda M and Kawamoto H: Small carcinomas of the thyroid.
A long-term follow-up of 867 patients. Arch Surg. 131:187–191.
1996. View Article : Google Scholar : PubMed/NCBI
|
